Aptadir
Trieste, Italy· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Aptadir is an Italian biotech startup founded in 2019 that develops aptamer-based RNA therapeutics designed to reprogram DNA methylation for the treatment of diseases. The company's platform technology, derived from foundational research, enables selective inhibition of the DNMT1 enzyme to alter gene expression in a targeted manner. Its initial focus is on developing treatments for intractable conditions like Myelodysplastic Neoplasms (MDS) and other cancers.
RNA & Gene Therapy